Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Barry P. Flannelly files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Herve Hoppenot - $19.77M in INCY purchases and sales in the last 12 months
- Pablo J. Cagnoni - $14.10M in INCY purchases and sales in the last 12 months
- Steven H. Stein - $6.27M in INCY purchases and sales in the last 12 months
- Patrick A. Mayes - $6.01M in INCY purchases and sales in the last 12 months
- Paul J. Clancy - $1.42M in INCY purchases and sales in the last 12 months
- Jesse Shefferman - $882K in TARA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Barry P. Flannelly?
Barry P. Flannelly is a corporate insider of Protara Therapeutics, Inc. (TARA). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Barry P. Flannelly last file a Form 4?
The most recent primary Form 4 on record is dated 16 June 2026, one of 6 filings going back to 2024.
Has Barry P. Flannelly been buying or selling stock?
Recorded transactions: 0 open-market purchases and 5 open-market sales ($1.21M) across all tracked filings.
